# Effect of Bromocriptine on Insulin Resistance in Polycystic Ovarian Syndrome - A Pilot Study

> **NCT02133755** · PHASE3 · UNKNOWN · sponsor: **IWK Health Centre** · enrollment: 60 (estimated)

## Conditions studied

- PCOS
- Insulin Resistance

## Interventions

- **DRUG:** Bromocriptine

## Key facts

- **NCT ID:** NCT02133755
- **Lead sponsor:** IWK Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2015-07
- **Final completion:** 2015-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2014-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02133755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02133755, "Effect of Bromocriptine on Insulin Resistance in Polycystic Ovarian Syndrome - A Pilot Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02133755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*